Literature DB >> 18608211

The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro.

Xiaojun Chen1, Wei Xiao, Xun Qu, Shengyu Zhou.   

Abstract

The beneficial effects of unfractionated heparin and low molecular weight heparin on cancer progression have been reported. In the study, the effect of dalteparin on pulmonary adenocarcinoma A549 cell line was observed in vitro. Our experiments revealed that: (1) dalteparin can inhibit the cell viability dose-dependently and time-dependently; (2) dalteparin can arrest the A549 cells in G(1) phase and induce them to early apoptosis; (3) dalteparin exerts its effects through p21(WAF1) and p27(KIP1) proteins; and (4) the changes of p21(WAF1) and p27(KIP1) proteins caused by dalteparin occurred at posttranscriptional levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608211     DOI: 10.1080/07357900801935631

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  2 in total

1.  Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.

Authors:  Guo-xing Zhong; Yi Gong; Chuan-jiang Yu; Shi-fei Wu; Qing-ping Ma; Yu Wang; Jiang Ren; Xue-chao Zhang; Wei-han Yang; Wen Zhu
Journal:  Tumour Biol       Date:  2015-01-27

2.  The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines.

Authors:  Y Carmazzi; M Iorio; C Armani; S Cianchetti; F Raggi; T Neri; C Cordazzo; S Petrini; R Vanacore; F Bogazzi; P Paggiaro; A Celi
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.